Tetraphase Pharmaceuticals

Patent cliffs & loss of exclusivity

An antibiotics company targeting multi-drug resistant bacterial infections

Company

AngelList URLhttps://angel.co/tetraphase-pharmaceuticals
Legal NameTetraphase Pharmaceuticals, Inc.
Company Operating StatusActive
Crunchbase URLhttps://www.crunchbase.com/organization/tetraphase-pharmaceuticals
Facebook URLhttps://www.facebook.com/pages/Tetraphase-Pharmaceuticals/198648703483350
Full Address201 Jones Road, Suite 400 Waltham, MA 02451
LinkedIn URLhttp://www.linkedin.com/company/tetraphase-pharmaceuticals?trk=tyah&trkInfo=tarId%3A1401424491653%2Ctas%3ATetraphase+Pharmaceuticals%2Cidx%3A1-1-1
Pitchbook URLhttps://pitchbook.com/profiles/company/42831-73#overview

2 upcoming patent cliffs

DrugIngredientTypeCliff
  1. XERAVAERAVACYCLINE DIHYDROCHLORIDESmall mol.Oct 2037
  2. XERAVAERAVACYCLINE DIHYDROCHLORIDESmall mol.Oct 2037

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

Tetraphase Pharmaceuticals — patent cliffs & loss of exclusivity | CliffBio